Literature DB >> 3426545

C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells.

S E Gargosky1, J C Wallace, F M Upton, F J Ballard.   

Abstract

1. Synthetic peptides corresponding to the five, seven, nine and eleven C-terminal amino acids of the tetradecapeptide bombesin as well as bombesin itself and gastrin-releasing peptide have been evaluated in Swiss 3T3 cells in order to define the minimal peptide length needed for biological responsiveness. 2. Gastrin-releasing peptide, bombesin, the undecapeptide and nonapeptide had nearly equipotent abilities to compete for binding of labelled gastrin-releasing peptide to the cell receptors and showed half-maximal competition at 5-10 nM. The heptapeptide and pentapeptide were ineffective. 3. Cross-linking experiments demonstrated specific binding of gastrin-releasing peptide to a 100 kDa receptor subunit. 4. Total cell protein synthesis was stimulated equally by the nonapeptide and longer peptides with a half-maximal effect at 0.5 nM, while a more than 1000-fold higher concentration of the heptapeptide was required to produce a similar response. Comparable results were found when insulin was also present. 5. Neither an inhibition of protein breakdown nor a stimulation of DNA labelling could be demonstrated by bombesin or gastrin-releasing peptide. 6. We conclude that a C-terminal peptide ligand comprising more than seven but no more than nine amino acids is required to achieve high-affinity binding and receptor-mediated responses via the bombesin receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426545      PMCID: PMC1148426          DOI: 10.1042/bj2470427

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  Early response pattern analysis of the mitogenic pathway in lymphocytes and fibroblasts.

Authors:  J C Metcalfe; T R Hesketh; G A Smith; J D Morris; A N Corps; J P Moore
Journal:  J Cell Sci Suppl       Date:  1985

2.  Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3.

Authors:  I Clark-Lewis; R Aebersold; H Ziltener; J W Schrader; L E Hood; S B Kent
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

3.  Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum.

Authors:  G L Francis; L C Read; F J Ballard; C J Bagley; F M Upton; P M Gravestock; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

4.  Changes in protein synthesis and breakdown rates and responsiveness to growth factors with ageing in human lung fibroblasts.

Authors:  F J Ballard; L C Read
Journal:  Mech Ageing Dev       Date:  1985-04       Impact factor: 5.432

5.  Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord.

Authors:  N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

6.  Comparison of the actions of bombesin, gastrin-releasing peptide-27, neuromedin B, and gastrin-releasing peptide-10 in causing release of gastrin and gastric inhibitory peptide in rats.

Authors:  G H Greeley; A Spannagel; F L Hill; J C Thompson
Journal:  Proc Soc Exp Biol Med       Date:  1986-10

7.  Neuromedin C: a bombesin-like peptide identified in porcine spinal cord.

Authors:  N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

8.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

9.  High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells.

Authors:  I Zachary; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH.

Authors:  S A Mendoza; J A Schneider; A Lopez-Rivas; J W Sinnett-Smith; E Rozengurt
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

View more
  5 in total

1.  Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

Authors:  M Ross; G L Francis; L Szabo; J C Wallace; F J Ballard
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

Review 2.  Techniques for molecular imaging probe design.

Authors:  Fred Reynolds; Kimberly A Kelly
Journal:  Mol Imaging       Date:  2011-12       Impact factor: 4.488

3.  High-affinity binding sites for bombesin on mouse colonic mucosal membranes.

Authors:  S Narayan; E Draviam; S Rajaraman; P Singh
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

4.  68Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation.

Authors:  Maliheh Hajiramezanali; Fatemeh Atyabi; Mona Mosayebnia; Mehdi Akhlaghi; Parham Geramifar; Amir Reza Jalilian; Seyed Mohammad Mazidi; Hassan Yousefnia; Soraya Shahhosseini; Davood Beiki
Journal:  Int J Nanomedicine       Date:  2019-04-10

5.  Bombesin analogue-mediated delivery preferentially enhances the cytotoxicity of a mitochondria-disrupting peptide in tumor cells.

Authors:  Hao Yang; Huawei Cai; Lin Wan; Shan Liu; Shengfu Li; Jingqiu Cheng; Xiaofeng Lu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.